Spotlight · Medical science
Jean Bennett Receives 2026 Breakthrough Prize in Life Sciences Recognition
Published November 08, 2026
The Breakthrough Prize Foundation named Jean Bennett among the 2026 Life Sciences laureates linked to gene therapies for inherited blindness.
Jean Bennett has been named a 2026 Breakthrough Prize in Life Sciences laureate in an award grouping that the Breakthrough Prize announcement links to gene therapies for inherited blindness.
Recognition in the 2026 laureates announcement
The official 2026 Breakthrough Prize announcement states that the Breakthrough Prize in Life Sciences was awarded to Jean Bennett, Katherine A. High and Albert Maguire. In its summary of the year’s life-sciences prizes, the Foundation says the honored work has led to gene therapies for inherited blindness, alongside other advances involving sickle cell disease, beta-thalassemia, ALS and frontotemporal dementia.
Why the prize is notable
The Breakthrough Prize positions its awards as recognition for discoveries that significantly drive the growth of human knowledge. In this context, Bennett’s recognition places her within one of the flagship life-sciences categories in the 2026 laureate class announced by the Foundation in Los Angeles.
Editorial scope
This Spotlight draft avoids adding detailed clinical-history claims beyond the official announcement. It focuses on the fact of the recognition, the named co-laureates and the description of the award area provided by the Breakthrough Prize Foundation.
Sources
This is an independent IQMIA editorial feature, not an endorsement or statement by the people mentioned.